Find clinical trials for Lymphoma in Valencia, VC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Valencia, VC, ESP:
on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...
Phase 3
Valencia, Spain and 163 other locations
Single-arm, open-label, multicenter, phase II trial aiming to include approximately 45 patients over 24 months. Patients will receive axicabtagene ci...
Phase 2
Valencia, Valencia, Spain and 14 other locations
and preliminary efficacy of relatlimab plus nivolumab in pediatric and young adult participants with recurrent or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Valencia, Spain and 76 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Valencia, Spain and 41 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Valencia, Spain and 214 other locations
phase II, response-adaptive, open-label, multicenter study aiming to include 80 patients in 78 months. Patients will receive 3 cycles of epcoritamab...
Phase 2
Valencia, Comunidad Valenciana, Spain and 14 other locations
with Refractory/Relapsing (R/R) KIR3DL2 positive Peripheral T Cell Lymphoma (PTCL) : Not Other Specified (NOS), PTCL-TFH (including Angioimm...
Phase 2
Valencia, Spain and 63 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Valencia, Valenciana, Comunitat, Spain and 67 other locations
adult patients diagnosed with indolent clinical forms of Mantle Cell Lymphoma (MCL). The study applies a Simon's two-stage design, with an i...
Phase 2
Valencia, Valencia, Spain and 15 other locations
to describe the efficacy and safety of patients with mantle cell lymphoma (MCL) receiving acalabrutinib in combination with R-CHOP for the f...
Phase 2
Valencia, Spain and 21 other locations
Clinical trials
Research sites
Resources
Legal